Type 2 diabetes diagnosis at age 30 can reduce life expectancy by up to 14 years

Research from Cambridge University - supported by by the Medical Research Council, British Heart Foundation, Health Data Research UK and NIHR Cambridge Biomedical Research Centre - suggests an individual diagnosed with type 2 diabetes at age 30 years could see their life expectancy fall by as much as 14 years.

Dr Stephen Kaptoge from the Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, stated:
“Given the impact type 2 diabetes will have on people’s lives, preventing – or at least delaying the onset – of the condition should be an urgent priority”

Professor Naveed Sattar from the Institute of Cardiovascular & Medical Sciences, University of Glasgow, added:
“Our findings support the idea that the younger an individual is when they develop type 2 diabetes, the more damage their body accumulates from its impaired metabolism. But the findings also suggest that early detection of diabetes by screening followed by intensive glucose management could help prevent long-term complications from the condition.”

This reinforces the need for accessible glucose monitors that can assist with early detection, or provide a user-friendly way to regularly measure glucose levels and maintain close glycemic control.

This is what will reduce the impact of diabetes on a person’s health, reduce the likelihood of developing unwanted complications, or becoming seriously ill due to mismanaged glucose levels.

This is NIQS’ mission.

Link to press release: https://lnkd.in/ehKguTxu

Link to paper: https://lnkd.in/eGKNrVap